ng-nitroarginine methyl ester has been researched along with Varicose Veins in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cenker, A; Nurullahoglu-Atalik, KE | 1 |
| Beauregard, KG; Khalil, RA; Qiao, X; Raffetto, JD | 1 |
| Khalil, RA; Raffetto, JD; Ross, RL | 1 |
3 other study(ies) available for ng-nitroarginine methyl ester and Varicose Veins
| Article | Year |
|---|---|
Moderate hypothermia attenuates α
Topics: Adrenergic alpha-1 Receptor Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hypothermia, Induced; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Phenylephrine; Receptors, Adrenergic, alpha-1; Signal Transduction; Spermatic Cord; Varicocele; Varicose Veins; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents; Veins | 2016 |
Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins.
Topics: Acetylcholine; Angiotensin II; Animals; Calcium Signaling; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Fulvestrant; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitriles; Phenols; Phenylephrine; Potassium Chloride; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Receptors, Estrogen; Receptors, G-Protein-Coupled; Sex Factors; Varicose Veins; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Vena Cava, Inferior | 2010 |
Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation.
Topics: Animals; Cromakalim; Cyclooxygenase Inhibitors; Dilatation, Pathologic; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; In Vitro Techniques; Indomethacin; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Male; Matrix Metalloproteinase 2; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptides; Phenylephrine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Potassium Chloride; Rats; Varicose Veins; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Vena Cava, Inferior | 2007 |